Sessions

Phenotypical versus target-based screening in CNS disorders: New directions for much-needed breakthroughs

[Speaker] Michael Spedding:1
1:Spedding Research Solutions, France

How regulatory aspects shape preclinical and clinical research

[Speaker] Daniel Hoyer:1,2,3
1:FMDH, School of Biomedical Sciences, Pharmacology and Therapeutics, University of Melbourne, Australia, 2:The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, Victoria 3052, Australia, 3:Department of Molecular Medicine, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA

Anticancer Effects and Mechanisms of MAM, a Natural Naphthoquinone

[Speaker] Xiuping Chen:1
[Co-author] Wen Sun:1, Hongwei Gao:1, Jin-Jian Lu:1
1:Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau

Drug Discovery form Natural Products and Traditional Medicine, Strategy and Applications

[Speaker] Guanhua Du:1
[Co-author] Lianhua Fang:1, Yuehua Wang:1, Li Zhang:1, Yang Lv:2, Lida Du:3, Ailin Liu:1, Juntian Zhang:1
1:Beijing Key Laboratory of Drug Target and Screening Research, Institute of Materia Medica, Chinese Academy of Medical College, Beijing, China, 2:Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China, 3:Medical School, The Chinese University of Hong Kong, China

Advanced Search